Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
9.23M
-
Shares change
-
+1.19M
-
Total reported value, excl. options
-
$77.6M
-
Value change
-
+$10.1M
-
Put/Call ratio
-
0.24
-
Number of buys
-
21
-
Number of sells
-
-11
-
Price
-
$8.49
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q4 2023
49 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q4 2023.
Profound Medical Corp. - Common Shares (PROF) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.23M shares
of 29.9M outstanding shares and own 30.9% of the company stock.
Largest 10 shareholders include GAGNON SECURITIES LLC (1.54M shares), FIL Ltd (1.2M shares), LETKO, BROSSEAU & ASSOCIATES INC (1.18M shares), Gagnon Advisors, LLC (679K shares), AIGH Capital Management LLC (647K shares), Raymond James Financial Services Advisors, Inc. (623K shares), Timelo Investment Management Inc. (612K shares), ROYCE & ASSOCIATES LP (564K shares), Rosalind Advisors, Inc. (533K shares), and ROYAL BANK OF CANADA (400K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.